Lai Chih-Cheng, Chen Chi-Chung, Lu Ying-Chen, Chuang Yin-Ching, Tang Hung-Jen
Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan.
Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan.
Infect Drug Resist. 2018 Dec 20;12:25-29. doi: 10.2147/IDR.S181201. eCollection 2019.
This study aimed to investigate the in vitro activity of cefoperazone-sulbactam against carbapenem-resistant and , and to evaluate the antibiotic resistance mechanisms of these bacteria.
In total, 21 isolates of carbapenem-resistant and 15 isolates of carbapenem-resistant with different pulsed-field gel electrophoresis types were collected for assessment of the in vitro antibacterial activities of cefoperazone and cefoperazone-sulbactam and the associated resistance mechanisms of the bacteria.
For carbapenem-resistant , the minimum inhibitory concentration (MIC) value and antibiotic susceptibility rate were similar for cefoperazone and cefoperazone-sulbactam (at 1:1 and 2:1 ratios). In contrast, for carbapenem-resistant , the MIC values, including the MIC range, MIC that inhibited 50% of isolates (MIC) and MIC that inhibited 90% of isolates (MIC), were reduced after treatment with sulbactam and cefoperazone. We screened resistance genes, including VIM-2, OXA-2 and OXA-10, in 21 carbapenem-resistant isolates. Only one (4.8%) of the isolates showed expression of VIM-2, and neither the OXA-2 nor the OXA-10 gene was detected. However, 20 (95.2%) isolates among the carbapenem-resistant isolates selected for oprD sequencing showed the phenomenon of nucleotide substitution or deletion. Among 15 carbapenem-resistant isolates, we found that ten (66.7%) isolates had concomitant expression of the OXA-23 and ISAba1-OXA-23 genes, and six (40.0%) isolates had expression of the OXA-24-like gene. All 15 isolates had OXA-51-like gene expression, and only 1 (6.7%) isolate had ISAba1-OXA-51-like gene expression. None of the isolates contained the IMP-1, IMP-8, KPC, NDM, VIM-1 or OXA-48 genes.
The in vitro antibacterial activity of cefoperazone against carbapenem-resistant can be enhanced by adding sulbactam to cefoperazone, but the addition does not affect carbapenem-resistant . This significant difference can be explained by the different resistance mechanisms of carbapenem-resistant and .
本研究旨在调查头孢哌酮-舒巴坦对耐碳青霉烯类[细菌名称1]和[细菌名称2]的体外活性,并评估这些细菌的耐药机制。
共收集了21株耐碳青霉烯类[细菌名称1]分离株和15株具有不同脉冲场凝胶电泳类型的耐碳青霉烯类[细菌名称2]分离株,以评估头孢哌酮和头孢哌酮-舒巴坦的体外抗菌活性以及细菌的相关耐药机制。
对于耐碳青霉烯类[细菌名称1],头孢哌酮和头孢哌酮-舒巴坦(1:1和2:1比例)的最低抑菌浓度(MIC)值及抗生素敏感率相似。相比之下,对于耐碳青霉烯类[细菌名称2],用舒巴坦和头孢哌酮处理后,MIC值(包括MIC范围、抑制50%分离株的MIC(MIC50)和抑制90%分离株的MIC(MIC90))降低。我们在21株耐碳青霉烯类[细菌名称1]分离株中筛选了耐药基因,包括VIM-2、OXA-2和OXA-10。仅1株(4.8%)分离株显示VIM-2表达,未检测到OXA-2和OXA-10基因。然而,在选择进行oprD测序的耐碳青霉烯类[细菌名称1]分离株中,20株(95.2%)出现核苷酸取代或缺失现象(此处原文表述有误,oprD是针对铜绿假单胞菌的外膜孔蛋白基因,原文前面说的是耐碳青霉烯类[细菌名称1],这里推测可能是[细菌名称1]为铜绿假单胞菌,若不是请根据实际情况调整)。在15株耐碳青霉烯类[细菌名称2]分离株中,我们发现10株(66.7%)分离株同时表达OXA-23和ISAba1-OXA-23基因,6株(40.0%)分离株表达OXA-24样基因。所有15株分离株均有OXA-51样基因表达,仅1株(6.7%)分离株有ISAba1-OXA-51样基因表达。所有分离株均未含有IMP-1、IMP-8、KPC、NDM、VIM-1或OXA-48基因。
头孢哌酮对耐碳青霉烯类[细菌名称1]的体外抗菌活性可通过向头孢哌酮中添加舒巴坦来增强,但添加后对耐碳青霉烯类[细菌名称2]无影响。这种显著差异可由耐碳青霉烯类[细菌名称1]和[细菌名称2]不同的耐药机制来解释。